Salix Pharmaceuticals, Ltd. Announces Acceleration Of Stock Option Vesting

RALEIGH, N.C.--(BUSINESS WIRE)--Jan. 5, 2006--Salix Pharmaceuticals, Ltd. (Nasdaq:SLXP) today announced that on December 30, 2005, the Company's Board of Directors, acting upon the recommendation of its independent Compensation Committee, approved the acceleration of the vesting of all outstanding unvested stock options. The acceleration was effective on December 30, 2005. The Board took the action with the belief that it is in the best interests of stockholders, as it will eliminate the Company's stock compensation expense in future periods in light of new accounting regulations effective beginning in fiscal year 2006.

Back to news